The latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV) causes cellular transformation and activation of several intracellular signaling events. In this report, we show that BLMP1 (encoded by the LMP1 gene derived from the B95-8 strain of EBV) triggers the expression of inducible nitric oxide synthase (iNOS) in Balb/3T3 fibroblasts. Intriguingly, NLMP1, a natural sequence variant of LMP1 identified in EBV-positive nasopharyngeal carcinoma biopsy, does not similarly induce iNOS expression. BLMP1-induced iNOS in Balb/3T3 cells is active to produce nitric oxide (NO), and NO production can be blocked by several iNOS inhibitors. When subjected to environmental stress, Balb/ 3T3 cells that produce NO lose viability more rapidly than non NO-producing cells. Blockage of NO generation by iNOS inhibitors enhances the viability of NOproducing cells under stress conditions. The activities of caspase-3 and c-Jun N-terminal kinase, two important regulators mediating stress-induced apoptosis, are significantly potentiated following heat shock treatment of BLMP1-expressing/NO-producing cells, compared to parental and NLMP1-expressing cells. Furthermore, treatment with iNOS inhibitor augmented the cloning efficiency (in culture) and tumor growth (in nude mice) of BLMP1-expressing/NO-producing cells. Collectively, the results demonstrate that BLMP1 induces iNOS expression and NO production in Balb/3T3 cells, which leads to the alteration of cell functions, including sensitivity to environmental stress, capability to colonize independent of anchorage and tumorigenicity in nude mice. Our data additionally implicate that the differential iNOS induction potential of the two LMP1 forms may represent the basis of a functional difference between the two LMP1 proteins.
Introduction
Nitric oxide (NO), a short-lived free radical produced by many cell types, is recognized as an important biological mediator in diverse physiological and pathological processes (Moncada et al., 1991; Nathan, 1992) . The compound is synthesized from L-arginine in an oxidative reaction catalyzed by nitric oxide synthase (NOS) isozymes, which generates NO and L-citrulline (Moncada et al., 1991) . Three NOS isoforms, namely neuronal NOS (nNOS or NOS1), inducible NOS (iNOS or NOS2), and endothelial NOS (eNOS or NOS3), have been identified and characterized (Bredt et al., 1990; Marsden et al., 1992; Nathan and Xie, 1994) . The nNOS and eNOS enzymes are constitutively expressed, whereas iNOS is induced de novo in many cell types by bacterial cell wall lipopolysaccharides, environmental stress and various cytokines, resulting in the production of large amounts of NO. For example, a well-characterized cytokine, tumor necrosis factora(TNF-a), induces iNOS expression in cells, either independently or via synergistic action with other inflammatory cytokines such as IL-1b and INFg (Kleinert et al., 1996) . In mouse macrophages, cooperative signaling by TNF receptor 1 (TNFR1) and TNF receptor 2 (TNFR2) is required for the maximal induction of iNOS by TNF-a (Riches et al., 1998) .
NOS expression has been linked to tumorigenesis. Elevated expression of NOS isoforms was observed in human gynecological, breast and central nervous system tumors, colon adenomas, esophageal adenocarcinomas, melanomas and prostate cancer (Thomsen et al., 1994 Cobbs et al., 1995; Ambs et al., 1998a; Wilson et al., 1998; Aaltoma et al., 2001; Massi et al., 2001) . In several of these cases, iNOS expression correlated well with tumor grade and could be detected in tumor endothelial cells, tumor-infiltrating immune cells, and/or tumor cells themselves, all of which are important regulators in the growth of solid tumors. Animal studies showed that a human colon adenocarcinoma genetically engineered to express iNOS constitutively grew faster than the wild-type cells in nude mice (Jenkins et al., 1995) , and inhibition of iNOS by a selective inhibitor reduced the growth of this xenografted tumor (Thomsen et al., 1997) . These observations implicate an oncogenic role of iNOS in human cancer. On the other hand, although low levels may prevent apoptosis of malignant cells and enhance tumor growth (Ambs et al., 1998b) , increased production of endogenous NO by tumor cells transfected with a functional iNOS gene has autotoxic effects, causing the suppression of tumor growth and metastasis via triggering of apoptosis (Xie and Fidler, 1998) .
Recently, a regulatory role for NO in controlling viral reactivation in EBV-infected cells was reported (Mannick et al., 1994; Kawanishi, 1995) . Low levels of iNOS were detected in EBV-infected B cells and epithelial cells, and NO production inhibited apoptosis and reactivation of EBV virus (Mannick et al., 1994; Gao et al., 1999) . However, to date, the identity of the viral protein responsible for iNOS induction is unclear.
Epstein-Barr virus (EBV) is a human herpes virus closely associated with several malignancies, including Burkitt's lymphoma (Esptein et al., 1964; Henle et al., 1968) , nasopharyngeal carcinoma (NPC) (Klein et al., 1974; Pathmanathan et al., 1995) , B-cell lymphoproliferative disease in immunosuppressed patients (Hanto et al., 1985) , peripheral T-cell lymphoma (Su and Hsieh, 1992) , and gastric carcinoma (Iwasaki et al., 1998) . EBV is maintained in the latent stage, which allows expression of a limited number of viral gene products . These gene products include EBV nuclear antigen 1 (EBNA1), which is essential for maintenance of the EBV episomal genome in EBV-positive cells, and latent membrane protein 1 (LMP1), present in more than 60% NPC and EBV-associated Hodgkin's lymphoma (Fahraeus et al., 1988) . LMP1 has oncogenic potential, since it transforms rodent fibroblast cells in vitro (Wang et al., 1985; Baichwal and Sugden, 1988) , and induces B cell lymphoma in transgenic mice model in vivo (Kulwichit et al., 1998) . LMP1 expression additionally affects the growth characteristics of B cells, epithelial cells and hematopoietic stem cells (Dawson et al., 1990; Fahraeus et al., 1990; Peng and Lundgren, 1992; Fairbairn et al., 1993) . Alteration of cell function by LMP1 may be due to its ability to induce the expression of numerous proteins, including B cell markers (CD23 and CD40), vimentin, cell adhesion molecule (ICAM1), epithelial growth factor receptor (EGFR), interleukin-10, cyclin D2, a calcium-camodulin-dependent protein kinase, and cyclooxygenase-2 (Birkenbach et al., 1989; Wang et al., 1990; Nakagomi et al., 1994; Mosialos et al., 1994; Arvanitakis et al., 1995; Murono et al., 2001) . Furthermore, up-regulation of Bcl-2 and A20 by LMP1 confers anti-apoptosis activity in B cells (Henderson et al., 1991; Laherty et al., 1992) .
The pleiotropic and profound effects of LMP1 on diverse biological processes appear to be due to its comparable properties to a constitutively active TNFR superfamily member Eliopoulos and Rickinson, 1998) . LMP1 is a 62 kDa polypeptide with a 25 amino acid N-terminus, a 161 amino acid transmembrane region and a 200 amino acid Cterminal cytoplasmic effector domain (Liebowitz et al., 1986) . Molecules such as TNFR-associated factors (TRAF) and TNFR-associated death domain protein (TRADD) interact directly with the C-terminal domain of LMP1 (Mosialos et al., 1995; Devergne et al., 1996; Izumi and Kieff, 1997) . These interactions are essential for LMP1-mediated activation of the transcription factor, NF-kB (Devergne et al., 1996; Sylla et al., 1998; Kieser et al., 1999) . Furthermore, kinase pathways, including NF-kB-inducing kinase (NIK) and cJun N-terminal kinase (JNK), responsible for the activation of transcription factors, NF-kB and AP-1, respectively are activated by LMP1 (Kieser et al., 1997; Sylla et al., 1998) .
At least two major variants of LMP1 genes have been reported, one derived from the B95-8 strain (designated BLMP1), and the other from NPC biopsies (NLMP1) (Hu et al., 1991; Chen et al., 1992) . NLMP1 mainly differs from BLMP1 by a 10 amino acid deletion in the C-terminal region (Chen et al., 1992) . Despite 95% sequence identity with BLMP1, NLMP1 is more tumorigenic than its homolog, as assessed in the rodent model (Chen et al., 1992; Li et al., 1996) and human keratinocytes (Hu et al., 1993) . Furthermore, the 10-amino acid deletion at the C-terminus appears to be essential for the higher transforming ability of NLMP1, compared to BLMP1 . These results indicate that sequence variation in the two LMP1 forms may have a profound effect on the biological activity of the proteins.
Since TNFR1 and 2 are responsible for iNOS induction in cells by TNF-a, and LMP1 mimics the TNFR superfamily, it is possible that LMP1 has a similar potential to trigger iNOS expression. In this report, we confirm that LMP1 induces iNOS expression, and consequently the production of large amounts of NO in Balb/3T3 cells. Interestingly, the induction potential of BLMP1 is much greater than that of NLMP1. Using biochemical and clongenic assays, we characterize the effects of iNOS induction/ NO production on Balb/3T3 cells. Furthermore, we examine the alteration of tumorigenicity of Balb/3T3 cells in nude mice when iNOS is induced by LMP1.
Results

LMP1 induces iNOS expression in Balb/3T3 cells
Inducible NO synthase (iNOS) is triggered by tumor necrosis factor-a (TNF-a) in Balb/3T3 cells (Kleinert et al., 1996) , resulting in the production of NO. Nitric oxide is toxic at levels above a certain threshold in cells. LMP1 is an integral membrane protein with biological functions mimic to the TNFR superfamily. However, LMP1 is constitutively activated, in contrast to the TNF receptor, which requires binding to TNF-a for activation. In order to examine whether LMP1 induces iNOS similar to TNF-a, unselected mixed G418-resistant cells generated by the transfection of expression vectors containing the two variants of iNOS induction by LMP1 of EBV J-S Yu et al LMP1, BLMP1 and NLMP1, together with a neogene-containing vector into Balb/3T3 cells, were analysed for iNOS expression by Western blotting. As shown in Figure 1a (left panel), BLMP1 induced high levels of iNOS in cells, following 2 week selection with G418. However, NLMP1 did not induce detectable levels of iNOS, unless the immunoblot was exposed for a long time (data not shown). Expression of LMP1 proteins in these cells was confirmed by immunoblot analyses with the S12 monoclonal antibody ( Figure 1a , right panel). Similar results were obtained when randomly selected individual cell clones stably expressing BLMP1 and NLMP1 were tested. Results displayed in Figure  1b show that iNOS expression was induced in BLMP1 clones (D4, D11 and D13), but not NLMP1 clones (E7, E9 and E14). As a positive control, high-level expression of iNOS was induced by TNF-a in Balb/ 3T3 cells (Figure 1b , lower panel, lane TNF-a).
In agreement with the above results, iNOS was additionally detected at the transcription level. The iNOS mRNA was highly expressed in BLMP1-expressing D4 and D11 clones, but not in NLMP1-expressing E9 and E14 cultures (Figure 1c) . To exclude the possibility that induction of iNOS by BLMP1 in Balb/3T3 cells occurs fortuitously during the clonal selection process, transient transfection experiments were performed. The RT -PCR data in Figure 1d confirm that transient transfection of LMP1 expression plasmids into Balb/3T3 cells induces iNOS mRNA, specifically, to a significantly higher level when the BLMP1-expressing vector is employed. The results demonstrate that LMP1 proteins induce iNOS expression, and the induction potential of BLMP1 is much greater than that of NLMP1.
NO production is significantly augmented in BLMP1-expressing Balb/3T3 cells Induction of iNOS results in NO production, which can be assayed by measuring the end products, nitrate and nitrite. To investigate whether this reaction occurs in BLMP1-expressing cells, the concentrations of nitrate and nitrite were determined in 3-day cultured medium of D11 and D13 cells. Our results (Table 1) show that 4.41 and 0.95 nmol nitrate and nitrite/ml were released in the medium from D11 and D13 (3610 5 cells), respectively. These findings correlate well with the higher levels of iNOS observed in D11 cells than D13 cells (Figure 1b) . On the other hand, parental, 3T3neo and NLMP1-expressing cell clones, without TNF-a (20 ng/ml) at 378C for 24 h. Extracts (60 mg) of parental cells, TNF-a-pretreated parental cells, BLMP1-and NLMP1-expressing cell clones were subjected to immunoblotting analyses with a monoclonal antibody against LMP1 (S12) and anti-iNOS antibody, respectively. Lane P, parental cells; lanes D4, D11 and D13, BLMP1-expressing cells; lanes E7, E9 and E14, NLMP1-expressing cells; lane TNF-a, TNF-a-treated parental cells. (c) Poly (A) + mRNA (10 mg) isolated from various cell clones was resolved by electrophoresis in a formaldehyde/1% agarose gel and transferred to a nitrocellulose membrane. After UV cross-linking, the membrane was hybridized with the 32 P-labeled probe for iNOS or b-actin, and the hybridized signal was detected as described in Materials and methods. (d) Balb/3T3 cells (3610 6 ) were transiently transfected with 1 mg pCMV vector, pCMVBLMP1 or pCMVNLMP1 expression plasmids by electroporation (BioRad electroporator) at 0.24 KV. Transfected cells were allowed to grow for 24 and 32 h, and harvested for RT -PCR analysis using the primers for iNOS, as described in Materials and methods ) were plated on 35-mm dishes containing 2 ml DMEM. The medium was replaced by 2 ml DMEM without phenol red, 4 h after plating. Culture medium (100 ml) was collected 24 h later, and subjected to nitrate/nitrate assays. (Table 1) .
The kinetics of NO production in LMP1-expressing cells was further assessed using the D11 clone expressing the highest levels of iNOS protein and parental cells treated with or without TNF-a. As presented in Figure 2a , parental cells only secreted small quantities of NO over 3 days in the absence of TNF-a, whereas a *2 -3-fold increase was observed in the presence of TNF-a. In contrast, NO production at day 3 in D11 cells was about eightfold higher than that in untreated parental cells alone (28 nmol nitrate and nitrite/ml in medium from D11 cells as compared to 3.5 nmol nitrate and nitrite/ml in parental cells without TNF-a treatment), and 3.5-fold higher than in TNF-atreated parental cells (28 nmol nitrate and nitrite/ml compared to 8 nmol nitrate and nitrite/ml). To certify that NO production was not due to the higher growth rate of D11 cells, a time-course study was performed. The amount of NO produced in D11 cells plated at 0.5, 1 and 5610 5 cells/ml was measured on days 1, 2, 3 and 4, respectively. As illustrated in the left panel of Figure  2b , NO production increased continuously over the 4 days, when cells were plated at low concentrations (0.5 6 -&-, 3610 5 -*-, and 1.5610 5 cells -*-) were seeded in 35-mm culture dishes containing 3 ml DMEM without phenol red, and cultured for 4 days. Culture supernatants (100 ml) were collected every 24 h, and subjected to a nitrate/nitrite assay. (Right panel) BLMP1-expressing D11 cells (1.5610 6 ) were seeded in a 35-mm culture dish containing 3 ml DMEM without phenol red. Culture supernatants (100 ml) were collected every 4 h, and subjected to a nitrate/nitrite assay and 1610 5 cells/ml). Higher plating concentrations (5610 5 cells/ml) showed a rapid initial increase, followed by a plateau in NO levels by day 2. The kinetics of the latter was further analysed by measuring NO production at shorter intervals. NO production in D11 cells increased linearly for 24 h, and reached maximum levels at *28 to 32 h ( Figure 2b , right panel).
Blockage of NO production in LMP1-expressing Balb/ 3T3 cells by iNOS inhibitors
To ensure that augmentation of NO production in LMP1-expressing Balb/3T3 cells is indeed due to the enzymatic reaction catalyzed by induced iNOS, the effects of several known iNOS inhibitors, including N G -monomethyl-L-arginine (L-NMMA), S-methylisothiourea (SMT) and dexamethasone (Dex), were tested in D11 cells. As shown in Figure 3a , treatment with any one of these compounds resulted in more than 70% NO reduction within 3 days, indicating that iNOS induced by LMP1 generates NO. All three compounds had little cytotoxic effect on the growth of D11 cells under our assay conditions (data not shown), and did not alter the expression of LMP1 in D11 cells ( Figure 3b ). Blockage of NO production by iNOS inhibitors in D11 cells may be due to the direct inhibition of pre-existing iNOS activity, synthesis of the enzyme, or both. To further evaluate this possibility, the level of iNOS in D11 cells was examined after prolonged treatment with inhibitor compounds. The concentration of iNOS did not change in SMT-and L-NMMA-treated cells ( Figure  3b ). In contrast, expression of iNOS in Dex-treated D11 cells was significantly inhibited. These results suggest that SMT and L-NMMA block iNOS activity in D11 cells, while Dex inhibits iNOS synthesis. Thus, at least two different mechanisms are potentially involved in the inhibition of NO production in D11 cells by these compounds.
LMP1-expressing, NO-producing cells are considerably sensitive to environmental stress
During the maintenance of individual cell clones, it was observed that BLMP1-expressing and NO-producing cultures always contained a significantly higher proportion of dead cells that detached from the culture dish. This phenomenon was less evident in parental, 3T3neo and NLMP1-expressing 3T3 cells. To investigate whether over-expression of BLMP1 enhances stress-induced cell death, the viability of BLMP1-expressing, NLMP1-expressing, 3T3neo and parental cells was investigated after treatment with various environmental stresses. Following prolonged culturing without replacing culture media, these four groups of cells exhibited similar viability over the initial 2 -3 days (Figure 4a ). However, on the fourth day, only *50% of BLMP1-expressing D11 cells remained viable, and cell death was observed on day 5, in contrast to more than 60% viability of parental, 3T3neo and NLMP1-expressing E9 cells. Similarly, D11 cells lost viability more rapidly than NLMP1-expressing E9, 3T3neo and parental cells after heat shock (Figure 4b ) and UV irradiation (Figure 4c ). These results collectively indicate that BLMP1-expressing, NO-producing Balb/ 3T3 cells are much more sensitive to environmental stress than NLMP1-expressing, 3T3neo and parental cells.
Potentiation of heat shock-induced activation of caspase-3 in LMP1-expressing NO-producing Balb/3T3 cells Prolonged culturing, heat shock and UV irradiation are typical environmental stress factors that trigger cellular apoptosis. Accordingly, the activity of caspase-3, an ICE/CED-3 family of cysteine proteases essential for apoptotic execution (Martins and Earnshaw, 1997; Nicholson and Thornberry, 1997) , was measured in BLMP1-expressing, NLMP1-expressing, 3T3neo and parental cells, following stress treatment. The basal activity of caspase-3 was low in all four cell types (Figure 5a ). When cells were subjected to heat-shock at 448C for 30 min, caspase-3 was dramatically activated in BLMP1-expressing, NO-producing D11 cells, but ) seeded in 35-mm culture dishes containing 2 ml DMEM without phenol red were treated with L-NMMA (50 mM), S-methylisothiourea (SMT) (25 mM) or dexamethasone (Dex) (25 mM) for 3 days, or left untreated. Culture supernatants (100 ml) were collected every 24 h, and assayed for nitrate/nitrite. (b) BLMP1-expressing D11 cells were harvested at day 3 after drug treatment, and 60 mg cell extracts were prepared for analysis of LMP1 and iNOS expression by immunoblotting not in parental, 3T3neo or NLMP1-expressing E9 cells. Similar results were observed in unselected/mixed clones expressing BLMP1 (Bmix) and NLMP1 (Nmix) (Figure 5b ), indicating that the significant caspase-3 activation in heat-treated D11 cells is not due to clonal variation during the selection process, but is caused by BLMP1 expression.
Heat shock induces persistent JNK activation in BLMP1-expressing, NO-producing Balb/3T3 cells In addition to caspase-3 activation, c-Jun N-terminal kinase (JNK) activated by environmental stress is pivotal for inducing apoptosis (Kyriakis et al., 1994; Derijard et al., 1994; Verheij et al., 1996) . JNK was immunoprecipitated from extracts of parental, 3T3neo, BLMP1-expressing D11 and NLMP1-expressing E9 cells with or without heat shock, followed by a kinase activity assay, using GST-c-Jun as substrate. Substantial activation of JNK to comparable levels occurred rapidly within 1 h upon heat-shock treatment of all four groups (Figure 6a) . However, interestingly, in parental, 3T3neo and E9 cells, levels of JNK activation dropped significantly to *10% at 6 h following treatment, whereas relatively high JNK activity (*40% maximum activation level) persisted in D11 cells at this time-point (Figure 6a ). This was additionally observed in unselected/mixed BLMP1-expressing clones, compared to parental, 3T3neo and NLMP1-expressing cell clones (Figure 6b ). The data indicate that the pattern of JNK activation induced by heat shock in D11 cells is distinct for BLMP1-expressing cells. 2 ) (c), and incubated at 378C for various time intervals, as indicated. Cell viability was determined by trypan blue exclusion Figure 5 Caspase-3 activity in parental and LMP1-expressing Balb/3T3 cells after heat shock treatment. (a) Parental, 3T3neo, BLMP1-expressing D11 and NLMP1-expressing E9 cells in 100 mm dishes were left untreated, or exposed to heat shock at 448C for 30 min, and incubated at 378C for another 1, 2, 4, and 6 h, respectively. Cells were harvested, and 100 mg cell extracts were analysed for caspase-3 activity, using Z-DEVD-AFC as the fluorogenic substrate, as described in Materials and methods. (b) Parental, 3T3neo and unselected/mixed clones of BLMP1-expressing (Bmix) or NLMP1-expressing (Nmix) Balb/ 3T3 cells were left untreated, or subjected to heat shock and incubated at 378C for 4 h. Cell extracts (100 mg) were analysed for caspase-3 activity, as described above. The experiment was repeated three times, with reproducible results
Stress-induced death of BLMP1-expressing, NOproducing cells is attenuated by iNOS inhibitors
To investigate whether NO production in BLMP1-expressing cells is responsible for enhanced sensitivity to stress, the effects of two iNOS inhibitors, aminoguanidine (AG) and L-NMMA, were examined in D11 cells. Examination of NO levels in cells treated with iNOS inhibitors revealed that by day 2, the production of NO in D11 cells was effectively blocked (Figure 7a) , and *70 -80% cells retained viability, compared to 560% control cells. This difference was more pronounced on the third day, whereby *15 to 25% cells retained viability in drug-treated cells, while viable cells were barely detected in the control cell group (Figure 7b) . Similarly, when D11 cells were grown in media containing iNOS inhibitors for 2 days and subsequently subjected to heat shock treatment, the percentage of viable cells increased by 15 -25% ( Figure  7c) . The results clearly demonstrate that NO produced by BLMP1-expressing clones is deleterious to the cells, and this effect may be attenuated by iNOS inhibitors that prevent NO synthesis in cells.
Effect of iNOS inhibitor on anchorage-independent growth of LMP1-expressing 3T3 cells in methylcellulose
It is known that LMP1 can transform Balb/3T3 cells (Wang et al., 1985; Baichwal and Sugden, 1988) . Moreover, cells expressing LMP1 acquire the ability to grow in an anchorage-independent manner, which is a classical method for the assessment of the oncogenic potential of a gene product. Since BLMP1 specifically induces iNOS expression and NO production, which in turn damages the cells, we attempted to determine Figure 6 JNK activity in parental and LMP1-expressing Balb/3T3 cells after heat shock treatment. (a) Parental, 3T3neo, BLMP1-expressing D11 and NLMP1-expressing E9 cells cultured in 100-mm dishes were left untreated or exposed to heat shock at 448C for 30 min, and incubated at 378C for another 1, 2, 4, and 6 h, respectively. Cells were harvested, and the activity of JNK1 immunoprecipitated from 500 mg cell extracts was measured, using GST-c-Jun (1-79) as substrate. The kinase reaction products were analysed by electrophoresis on a 12.5% SDS-gel, and phosphorylated GST-c-Jun (1 -79) was identified by autoradiography (left panel). Relative JNK1 activity in each sample was quantified with a densitometer (right panel). (b) Parental, 3T3neo, unselected/mixed clones of BLMP1-expressing (Bmix) and NLMP1-expressing (Nmix) Balb/3T3 cells were left untreated, or subjected to heat shock and incubated at 378C for 6 h. JNK1 activity was measured from 500 mg cell extracts as described above. The experiment was repeated three times with reproducible results iNOS induction by LMP1 of EBV J-S Yu et al whether iNOS expression/NO production affects the anchorage-independent growth of cells containing BLMP1. BLMP1-expressing D11 and D13 cells were cultured in medium containing methylcellulose, in the presence and absence of 1 mM AG for 2 weeks, and the numbers of the resulting colonies were scored. D11 and D13 cells formed colonies in methylcellulose, both in the presence and absence of AG (result not illustrated). However, more colonies (14 -25%) of BLMP1-expressing D11 and D13 cells were observed in the presence of AG, compared to cells cultured in the absence of the inhibitor (Table 2) . This was more obvious in the D11 clone, which expresses higher levels of iNOS. In contrast, approximately 30% reduction in colony formation was observed when E9 cells were tested in the presence of AG ( Table 2) . As the controls, both parent and 3T3neo cells could only grow very few spontaneous colonies without or with AG under the same condition (Table 2 ). These results signify that BLMP1-mediated iNOS induction in Balb/3T3 cells attenuates the ability of the cell to grow in an anchorage-independent manner.
Effect of iNOS inhibitor on the growth of LMP1-expressing 3T3 cells in nude mice
We further examined the possible role of iNOS induction in the tumorigenicity of LMP1-expressing 3T3 cells in vivo. Cell clones including 3T3neo, E9, D11 and D13 were inoculated subcutaneously into nude mice, which were administrated intraperitoneally with or without AG (200 mg/kg) every other day until day 45. All mice tolerated well this regime. No tumors were formed in mice injected with 3T3neo cells, either in the presence or absence of AG. Without AG treatment, subcutaneous tumors arose in all the mice inoculated with E9 or D11 cells, with the E9 clone-derived tumors growing much faster than those from D11 cells ( Figure   Figure 7 Effect of iNOS inhibitors on the viability of D11 cells under stress. (a,b) D11 cells (6610 5 cells) were cultured in 35-mm dishes containing 3 ml DMEM in the absence and presence of 1 mM AG or L-NMMA for 1 -3 days without refreshing the medium. The amount of nitrate/nitrite in culture supernatants (a) and cell viability (b) was analysed every 24 h. (c) D11 cells (6610 5 cells) were cultured in the absence and presence of 1 mM AG or L-NMMA for 2 days. Non-viable cells were removed by replacing the culture media, and viable cells were treated with heat shock (448C for 30 min) and incubated at 378C for another 4 h. Cell viability was subsequently determined as described above 8a). Only one of the four D13 clone-injected mice grew palpable tumor by day 45. AG treatment had little effect on the kinetics of E9 clone-derived tumor formation, but significantly enhanced the growth rate of D11 and D13 clone-derived tumors (Figure 8a) . Interestingly, all four mice who received D13 cells developed tumors in the presence of AG. AG treatment systematically caused a reduction of the plasma nitrate/nitrite levels in all the three groups of mice (Figure 8b ), indicating the efficacy of AG to reduce NO production in mice. Immunoblot analysis confirmed the expression of LMP1 and iNOS of the cells cultured from E9, D11 or D13 clone-derived tumor mass, and the patterns were almost identical to those observed from these cells prior to being injected into mice (Figure 8c) . In another experiment, we further examine the dose effect of AG on the growth of D11 clone-derived tumors in nude mice. Again, tumors grew faster in the AG-treated mice than in the control group. At day 29, the average tumor size was more than twofold larger in the presence of 200 mg/kg AG and was almost fourfold in the presence of 400 mg/kg AG (Figure 8d ). Thus, results collectively support that inhibition of iNOS by iNOS inhibitor enhances the tumor formation activity of BLMP1-expressing cell clones.
Discussion
Following the identification of an LMP1 variant, NLMP1, from NPC biopsies (Chen et al., 1992; Hu et al., 1993) , efforts have been made to distinguish the functional role of this protein in relation to BLMP-1 from B95-8 cells. It is known that NLMP1 is more oncogenic than BLMP1 (Chen et al., 1992; Hu et al., 1993; Li et al., 1996) and less immunogenic (Trivedi et al., 1994) . Furthermore, although both BLMP1 and NPC-derived LMP1 activate transcription factors, NFkB and AP-1, it appears that NLMP1 functions more efficiently in Jurkat cells (Fielding et al., 2001 ), but not C33A cells (Yeh et al., 1997) . Additional reports demonstrate that the expression levels of several cell surface molecules (CD40, CD44, and CD54), interleukins-6 and -8, and epidermal growth factor receptor differ between BLMP1-and NLMP1-expressing cells (Johnson et al., 1998; Miller et al., 1998; Dawson et al., 2000) . Using Balb/3T3 cells as a model in this study, we show that BLMP1 induces considerably higher iNOS expression, which may be the basis of another functional difference between the two LMP1 proteins.
The constitutive iNOS in BLMP1-expressing Balb/ 3T3 cells is catalytically active in NO synthesis, since a significant amount of the metabolic end products are detected in the culture supernatant (Table 1 ). In the BLMP1-expressing D11 clone, which exhibits the highest iNOS levels, NO production was 2 -3-fold higher than that released from TNF-a-treated parental cells (Figure 2a) . NO was either toxic or protective, depending on its chemistry in a given biological milieu (Moncada et al., 1991) . NO has cytotoxic effects at high concentrations, whereas at lower concentrations, the compound may have the opposite effect and protect against apoptotic cell death from diverse stimuli (Dimmeler and Zeiher, 1997; Muschel et al., 1998) . To understand the possible biological functions of constitutively expressed iNOS, we evaluated the effects of NO on LMP1-expressing cells. Several lines of evidence indicate that iNOS induction and NO production due to BLMP1 expression has deleterious effects on cells. Firstly, BLMP1-expressing, NO-producing cells lost viability more rapidly than parental, 3T3neo and NLMP1-expressing Balb/3T3 cells under various environmental stress conditions (Figure 4) . Secondly, enhanced activation of caspase-3 was observed in BLMP1-expressing, NO-producing cells during heat shock treatment ( Figure 5 ). Thirdly, blockage of NO production by iNOS inhibitors (AG and L-NMMA) in these cells partially prevented cell death during environmental stress (Figure 7) . Overall, these results suggest that Balb/3T3 cells harboring BLMP1 are considerably more sensitive to environmental stress than those expressing NLMP1. This finding is consistent with previous reports that overexpression of BLMP1 is toxic to many cell lines, including six human B lymphocyte lines, Balb/3T3 fibroblasts, 143/EBNA 1 cells (human osteosarcoma cell line expressing EBV EBNA-1 gene), HEp-2 cells (human carcinoma cell line) (Hammerschmidt et al., 1989) and human epithelial cell line RHEK-1 (Lu et al., 1996) . Furthermore, the cytotoxic effect of BLMP1 expression on Balb/3T3 cells is mediated, at least in part, through induction of iNOS and the subsequent production of nitric oxide.
Stable or transient expression of BLMP1 and NLMP1 activates the JNK pathway in epithelial or B cells (Kieser et al., 1997; Eliopoulos and Young, 1998; Dawson et al., 2000) . Stable expression of both BLMP1 and CAO-LMP1 (resembling NLMP1 in this study) in BL41 Burkitt lymphoma and SCC12F human epithelial cells resulted in low-level (2 -3-fold), but constitutive activation of JNK (Eliopoulos and Young, 1998; Dawson et al., 2000) . However, in this study, we observed little or no JNK activation in Balb/3T3 cells stably expressing BLMP1 or NLMP1, compared to parental or 3T3neo cells (Figure 6 ). Interestingly, the kinetics of JNK activation in Balb/3T3 cells stably expressing BLMP1 or NLMP1 was distinct in response to heat shock treatment. In contrast to the rapid and transient JNK activation in NLMP1-expressing E9, 3T3neo and parental cells, BLMP1-expressing, NOproducing D11 cells exhibited prolonged JNK activation after heat shock (Figure 6a) . Similarly, at later stages, i.e., 6 h after heat shock, relatively higher levels of activated JNK were detected in unselected/mixed clones expressing BLMP1 than in parental, 3T3neo and NLMP1-expressing cells (Figure 6b ). These findings imply that the upstream mechanism(s) regulating JNK activity in Balb/3T3 cells may be altered significantly by BLMP1, but not NLMP1. As activation of JNK was not impaired in either BLMP1-or NLMP1-expressing Balb/3T3 cells, the mechanism(s) responsible for the down-regulation of stress-induced JNK activity in Balb/3T3 cells may be affected by BLMP1, but not NLMP1.
The hypothesis that the duration of JNK activation may be a determining factor in cell death or proliferation is further supported by several recent studies suggesting that JNK activation is required for caspase activity during apoptosis triggered by variety stimuli (Seimiya et al., 1997; Chan et al., 2000; MacFarlane et al., 2000) . In the present study, we found that during the later stages of heatshock treatment, enhanced caspase-3 activation in BLMP1-expressing, NO-producing D11 cells correlated well with the sustained high levels of JNK activity (see Figures 5a and 6a for comparisons) . Therefore, it is feasible that the enhanced sensitivity of these cells to environmental stress is attributed to the alteration of JNK-mediated caspase activation.
At present, the mechanism by which specific expression of BLMP1 in Balb/3T3 cells affects the regulation of JNK and/or caspase activities is unknown. One possibility is that BLMP1 induces large quantities of NO, which is deleterious to cells. To examine this theory, we investigated the effects of iNOS inhibitors (AG and L-NMMA) on heat shockinduced caspase-3 activation in BLMP1-expressing, NO-producing D11 cells. Although more than 70% NO production was inhibited by pretreatment with 1 mM AG or L-NMMA, levels of heat shock-induced caspase-3 in D11 cells were not affected (data not illustrated). A simple explanation is that NO may not be the sole cause for BLMP-expressing cell susceptibility to stress-induced apoptosis, although the possible significance of NO in this process cannot be excluded. It is known that long-term exposure to high doses of NO leads to S-nitrosylation involving the transfer of a nitric oxide group to cysteine sulfhydryls onto cellular targets, including metabolic, structural and signaling proteins (Stamler, 1994; Jaffrey et al., 2001) . This may in turn lead to irreversible cell damage, irrespective of the further addition of iNOS inhibitors. In this context, NO-producing cells may be particularly susceptible to damage, despite temporary treatment with iNOS inhibitors. Both BLMP1 and NLMP1 induce transformation of Balb/3T3 cells when the LMP1 gene is driven by an appropriate promoter. LMP1-transformed cells grow as colonies in an anchorage-independent manner (Baichwal and Sugden, 1988; Chen et al., 1992; . In concurrence with these reports, we observed that all three clones employed in the present study (BLMP1-expressing D11 and D13, and NLMP1-expressing E9 clones) formed colonies in methylcellulose, and the number of colonies significantly increased (14 -25%) in NO-producing BLMP1 clones, D11 and D13 (Table 2) . Moreover, in D11 cells, the percentage increase in colonies following AG treatment corresponded to enhanced cell viability (*20%) under stress (see Table 2 and Figure 7 for comparison). This specific effect of iNOS inhibition by AG on the anchorage-independent growth of BLMP1-expressing cells was not observed in NLMP1-expressing E9 cells, which exhibit undetectable levels of iNOS (Table 2 ). In fact, AG treatment resulted in fewer E9 colonies. The reason for the differential response of BLMP1-and NLMP1-expressing cells to iNOS inhibitors is currently unknown. However, these results imply that the cellular levels of NO play an important role in the anchorage-independent growth of BLMP1-expressing Balb/3T3 cells. Therefore, in addition to inducing considerable susceptibility to stress-triggered cell death, iNOS expression/NO production may affect cell growth in methylcellulose. This finding is not unexpected, since growth of an adherent cell in a semi-solid background or in suspension acts as a stress inducing factor leading to anoikis, a special type of apoptosis (Frisch and Ruoslahti, 1997; Valentinis et al., 1999) .
The possible role of iNOS induction in the LMP1-mediated transformation was further evaluated by nude mice model in vivo. Albeit the effects of iNOS inhibition with respect to the in vitro functional tests were small (Table 2 and Figure 7) , administration of AG caused a quite significant enhancement of the tumor growth in mice inoculated with the NOproducing, BLMP1-expressing D11 and D13 cells (Figure 8 ). In contrast, this treatment had no obvious effect on the growth of tumor derived from NLMP1-expressing E9 cells. The results clearly show that these cells respond to AG in a similar trend both in vitro and in vivo. It is known that AG is not a specific inhibitor for iNOS. It can also inhibit diamine oxidase, the ratelimiting enzyme in terminal catabolism of polyamines, and the formation of highly reactive advanced glycosylation end products that are linked to tissue damage in diabetes and aging (for review, see Nilsson, 1999) . Therefore, the side effects of AG resulted from the inhibition of the two pathways can not be ruled out in the present study. However, the efficacy of AG to inhibit NO production in vitro and in vivo demonstrated in this study and in mice infected with lymphocytic choriomeningitis virus (LCMV) (Campbell, 1996) , as well as the profound effects of iNOS expression in the growth or apoptosis of tumors (Jenkins et al., 1995; Thomsen et al., 1997; Ambs et al., 1998b; Xie and Fidler, 1998) strongly implicate the role of iNOS expression/NO production in attenuating the LMP1-mediated transformation.
In conclusion, we show that BLMP1, but not NLMP1, induces iNOS expression and NO production in Balb/3T3 cells. This biological activity may be significant in distinguishing between the functional roles of the BLMP1 and NLMP1 proteins.
Materials and methods
Materials
[g-32 P]ATP was purchased from Amersham (Buckinghamshire, UK). Polyvinylidene fluoride (PVDF) membrane was obtained from Millipore (Bedford, MA, USA). Dulbecco's modified Eagle's medium (DMEM), dexamethasone, methylcellulose, goat anti-rabbit and anti-mouse IgG antibodies conjugated with alkaline phosphatase were from Sigma (St. Louis, MO, USA). DMEM without phenol red was purchased from GIBCOBRL. and anti-JNK1 (C17) antibodies were procured from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-LMP1 monoclonal antibody, S12, was generated by Dr Thorley-Lawsen. Nitrate/nitrite assay kits were from Cayman Chemical Co. (Ann Arbor, MI, USA). N G -monomethyl-L-arginine (L-NMMA), S-methylisothiourea (SMT), aminoguanidine (AG) and Z-DEVD-AFC were from Calbiochem (La Jolla, CA, USA). CDP-Star TM (a chemiluminescent substrate for alkaline phosphatase) was obtained from Boehringer Mannheim (Mannheim, Germany). Molecular weight marker proteins (Mark12) were from Novel Experimental Technology (San Diego, CA, USA). BCA protein assay reagent and Protein ASepharose CL-4B were supplied by Pierce (Rockford, IL) and Amersham Pharmacia Biotech AB (Uppsala, Sweden), respectively. GST-c-Jun (1-79) was expressed in E. coli and purified with a glutathione affinity column for JNK activity assays (Chan et al., 2000) .
Cell culture and drug treatment
Mouse Balb/3T3 fibroblasts were cultured at 378C in a 95% air/5% CO 2 and water-saturated atmosphere in DMEM supplemented with 10% heat-inactivated fetal bovine serum, 100 U/ml penicillin and 100 mg/ml streptomycin. Stable Balb/ 3T3 cell lines expressing BLMP1 and NLMP1 were generated by co-transfection of BLMP1-expressing vector (pEcoD4) and NLMP1-expressing vector (pT7E) with pSV2neo (containing neomycin-resistance gene) (Chen et al., 1992; Li et al., 1996) , followed by Geneticin sulfate (G418) selection for 2 weeks. Individual cell clones stably expressing BLMP1 and NLMP1 were further selected from mixed clones. Similarly, 3T3neo cells were established by transfection of pSV2neo into Balb/3T3 cells, followed by selection with G418.
For drug treatment, cells (*5 -6610 5 ) were plated onto 35-mm culture dishes containing 2 ml DMEM. Four hours after plating, the medium was replaced by 2 ml DMEM without phenol red, and cells were incubated with or without L-NMMA (50 mM), S-methylisothiourea (25 mM) or dexamethasone (25 mM) for 1, 2 and 3 days, respectively. High doses of iNOS inhibitor, aminoguanidine or L-NMMA (1 mM), were used when required. Small aliquots (0.2 ml) of the medium were removed at various time-points and stored at 7208C for the determination of nitrate/nitrite content. Cells were washed twice with ice-cold PBS and lysed in 250 ml solution A (20 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 1 mM benzamidine, 1 mM phenylmethylsulfonyl fluoride, 50 mM NaF, 20 mM sodium pyrophosphate, 1 mM sodium orthovanadate) on ice for 10 min. Cell lysates were collected and sonicated on ice (model W-380, Heat Systems-Ultrasonics) for 3610 s at 50% power output, followed by centrifugation at 15 000 g for 20 min at 48C. The resulting supernatants were used as cell extracts.
Environmental stress
Cells (*5 - 6610 6 ) were plated on 100-mm culture dishes 24 h before the experiment, and subsequently subjected to heat shock or UV irradiation, as previously described Tang et al., 1998) . Briefly, heat shock treatment was performed by placing culture dishes in a 448C water bath for 30 min, and incubating at 378C in a CO 2 incubator for indicated intervals. Ultraviolet irradiation (254 nm, UVC) was achieved with a UV gene linker (UV Stratalinker, model 1800, Stratagene, La Jolla, CA, USA) equipped with energy output control. Prior to irradiation with UV light at 200 J/ m 2 , medium was removed from the culture dish. The medium was immediately added back into the dish after UV irradiation, and incubated at 378C in a CO 2 incubator for the various time intervals indicated.
Cell viability assay
Cell viability was determined using the trypan blue exclusion test. Briefly, cultured cells after treatment were trypsinized from the culture dish, and an equal volume of trypan blue solution was mixed with cell suspensions for staining. Stained non-viable and unstained viable cells were counted over several days. Cell viability was represented as a percentage of the ratio of viable to total (viable and non-viable) cell number.
Northern blot analysis
Total RNA was isolated from cultured cells with the RNeasy Midi Kit (Qiagen), and Poly (A) + mRNA was purified by Oligotex Direct mRNA Kit (Qiagen), according to manufacturer's instructions. Probes were prepared by reverse transcription-polymerase chain reaction (RT -PCR) amplification, and labeled, using a random priming kit (Amersham). For iNOS, the oligonucleotide primers, IN-1 (5'-GTGAGG-ATCAAAAACTGGGG-3') and IN-2 (5'-ACCTGCAGGTT-GGACCAC-3'), were synthesized as described by . b-actin mRNA detected by a probe corresponding to part of b-actin cDNA was used as an internal control. For Northern blot analysis, 10 mg poly(A) + mRNA isolated from various cell clones was resolved by electrophoresis in a formaldehyde/1% agarose gel, and transferred to a nitrocellulose membrane. After UV cross-linking, the membrane was hybridized to 32 P-labeled probes at 688C, and washed in high-stringency conditions (0.26standard saline citrate/0.1% SDS at 558C). Autoradiography was performed by exposure of the washed membrane to BioMax film (Kodak).
RT -PCR analysis for iNOS expression
Total RNA was prepared from freshly harvested, transfected Balb/3T3 cells, using TRIzoltm, according to manufacturers' instructions (Gibco). Oligonucleotide primers specific for iNOS, IN-1 and IN-2 were prepared. Primer IN-2 was selected for the reverse transcription-polymerase chain reaction (RT -PCR). PCR amplification of iNOS performed as described previously yielded a 380-bp fragment. Denaturation, annealing, and elongation temperatures for PCR were 94, 55, and 728C, respectively, at 1 min each for 32 cycles, followed by a final 10 min extension at 728C. PCR products were separated by agarose gel electrophoresis, transferred to nylon membranes (Hybond-N, Amersham, UK), and the iNOS gene was detected by Southern blot hybridization to a specific radiolabeled probe.
Nitrate/nitrite assays
The amount of NO produced by cells was indirectly measured by the formation of nitrate (NO 3 -) and nitrite (NO 2 -) (two stable end products of NO) in culture supernatants. The total amounts of nitrate and nitrite were determined with the nitrate/nitrite assay kit (Cayman Chemical Co.), using manufacturer's protocols. Briefly, supernatant (80 ml) was incubated with nitrate reductase (20 ml) at room temperature for 1 h, followed by incubation with 100 ml Griess reagent (1% sulfanilic acid, 0.1% naphtylethylenediamine dihydrochloride, 2.5% phosphoric acid) for 10 min. The optical density of each sample was analysed at 540 nm in a microplate reader with sodium nitrite as a standard. For measurement of the plasma nitrate/nitrite levels, the plasma derived from blood samples were first clarified by centrifugal ultrafiltration (Microcon YM-30 Filter Devices, Millipore, Bedford, MA, USA). The filtered plasma was then processed as described above.
Immunoblots
Immunoblotting was carried out essentially as described in previous reports (Yu and Yang, 1994) . Briefly, cell extracts were resolved on SDS gels and electroblotted onto PVDF membranes. Membranes were probed with anti-iNOS antibody (0.2 mg/ml) or anti-LMP1 monoclonal antibody, S12 (0.25 mg/ml) (Mann et al., 1985) . Proteins of interest were detected with goat anti-rabbit or anti-mouse IgG antibody conjugated with alkaline phosphatase, and CDP-Star TM (a chemiluminescent substrate for alkaline phosphatase), using manufacturers' protocols. For re-probing the same membrane with another type of antibody, the blotted membrane was initially incubated with 200 ml stripping buffer (62.5 mM Tris-HCl, pH 6.7, 100 mM 2-mercaptoethanol, 2% SDS) at 508C for 30 min, with occasional agitation to strip off bound antibodies. After washing three times in TTBS buffer (20 mM Tris-HCl, pH 7.4, 0.5 M NaCl, 0.05% Tween-20), the stripped membrane was probed with another antibody.
